MolNFT v1 · #103931 · protein
Phl P 4 I153V variant, a glucose oxidase
4PVJ · Pollen allergen phl P 4.0202: “Phl P 4 I153V variant, a glucose oxidase”. X-ray diffraction, 2 ligands (FAD, NA), 2 pockets (best druggability 0.83). MolNFT v1 #103931 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4PVJ
- Type
- protein
- Length
- 490 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Pollen allergen phl P 4.0202
- UniProt
- B2ZWE9
- Ligands
- FAD, NA
- Pockets
- 2 · best druggability 0.83
Structure
x-ray diffraction · 1 distinct chain · 36% helix, 21% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Pollen allergen phl P 4.0202 | protein | 490 | 36% helix, 21% strand | B2ZWE9 |
Ligands and binding sites
- FAD · Flavin-adenine dinucleotide · ligand · chains A
- NA · Sodium ion · metal · 2 copies · chains A
- MLI · Malonate ion · additive · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 590 | 0.83 | 0.88 | 79 | FAD |
| 2 | 50 | 0.37 | 0.81 | 20 | empty |
Modifications
Observed in the structure: 2 cofactor, 2 disulfide (flavinylation, disulfide).
Compared structures
- 4PVJ · Phl p 4 I153V variant, a glucose oxidase · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt B2ZWE9
- Elsewhere: RCSB PDB 4PVJ · PDBe 4PVJ · UniProt B2ZWE9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.